Bioporto ASTHOXF 66 Days Inventory is 754.92 as of Dec. 2025, which is 424% above its 10-year median of 144.16. GuruFocus rates THOXF with a GF Score™ of 66/100 and a GF Value™ of $0.17. The stock has 3 warning signs investors should review. Among 176 Medical Diagnostics & Research companies, Bioporto AS ranks worse than 86.36% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Bioporto AS's Average Total Inventories for the
three
months ended in Dec. 2025 was $1.17 Mil. Bioporto AS's Cost of Goods Sold for the
three
months ended in Dec. 2025 was $0.14 Mil.
Hence, Bioporto AS's Days Inventory for the
three
months ended in Dec. 2025 was 754.92.
The historical rank and industry rank for Bioporto AS's Days Inventory or its related term are showing as below:
THOXF'
s Days Inventory Range Over the Past 10 Years
Min: 97 Med: 144.16 Max: 289.52
Current: 222.78
During the past 13 years, Bioporto AS's highest Days Inventory was 289.52. The lowest was 97.00. And the median was 144.16.
THOXF's Days Inventory is ranked worse than 86.36% of 176
companies
in the Medical Diagnostics & Research industry
Industry Median: 68.88
vs THOXF: 222.78
Bioporto AS's Days Inventory
increased
from Dec. 2024 (104.63) to Dec. 2025 (754.92).
It might indicate that Bioporto AS's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Bioporto AS's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.12.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bioporto AS's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 0.64.
Bioporto AS (OTCPK:THOXF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Bioporto AS's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bioporto AS's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Bioporto AS Days Inventory Related Terms
Bioporto AS Days Inventory Historical Data
* Premium members only.
The historical data trend for Bioporto AS's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
THOXF vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Bioporto AS's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioporto AS Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Bioporto AS's Days Inventory distribution charts can be found below:
* The bar in red indicates where Bioporto AS's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioporto AS (THOXF) has a Days Inventory of 754.92 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Bioporto AS and its competitors. This is 424% above median its historical median of 144.16. Over the past decade, Bioporto AS's Days Inventory has ranged from 97.00 to 289.52. According to the industry distribution chart, Bioporto AS ranks #152 out of 176 companies in the Medical Diagnostics & Research industry, placing it in the top 86.4%.
Is Bioporto AS's Days Inventory too high?
Bioporto AS's current Days Inventory of 754.92 is 424% above median its 10-year median of 144.16. Over the past 10 years, this metric has ranged from a low of 97.00 to a high of 289.52. The Medical Diagnostics & Research industry median Days Inventory is 68.88. Bioporto AS's value of 754.92 is 996% above this industry median. Based on the distribution chart, Bioporto AS ranks #152 out of 176 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Bioporto AS has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does Bioporto AS's Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Bioporto AS ranks #152 out of 176 companies for Days Inventory. This places Bioporto AS in the lower half of its industry. The industry median Days Inventory is 68.88. Bioporto AS's value of 754.92 is 996% above this benchmark. Historically, Bioporto AS's own Days Inventory has ranged from 97.00 to 289.52 over the past decade. While the company's 10-year median is 144.16 vs. the industry median of 68.88, Bioporto AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 68.88, based on 176 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioporto AS's current Days Inventory of 754.92 is 996% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Bioporto AS and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 68.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioporto AS's current Days Inventory is 754.92, which is 424% above median its own 10-year median of 144.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioporto AS stock overvalued right now?
Bioporto AS (THOXF) has a current Days Inventory of 754.92. The stock's GF Value™ is $0.17, compared to a current price of $0.15 — trading 12.4% below its estimated fair value. The current Days Inventory is 754.92, which is 424% above median its 10-year median of 144.16 and 996% above the Medical Diagnostics & Research industry median of 68.88. Bioporto AS's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Bioporto AS (THOXF), the current Days Inventory is 754.92 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioporto AS (THOXF) Overvalued in 2026?
Based on GuruFocus' analysis, Bioporto AS stock appears to be undervalued.
The current stock price of $0.15 is trading 12.4% below its estimated GF Value™ of $0.17.
Key valuation signals for THOXF:
Days Inventory: 754.92 (424% above median its 10-year median of 144.16)
GF Value™: $0.17 vs. price of $0.15 (12.4% below fair value)
Industry Position: 996% above the Medical Diagnostics & Research median (#152 of 176)
No single metric tells the full story. See the THOXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's products include the NGAL Test, ELISA kits, Antibodies, and Other products and licenses. Geographically, it derives a majority of its revenue from North America. Geographically, its business area is in North America, Denmark, and rest of Europe, and Asia. The products of the company involve: ProNephro AKI, The NGAL Test, Antibodies, ELISA Kits, gRad Lateral Flow, and others.
66GF Score
Get the complete analysis for THOXF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
THOXF has been successfully added to your 
